Author:
Lewallen Susan,Courtright Paul
Publisher
Springer International Publishing
Reference14 articles.
1. Hogeweg M, Kiran KU, Suneetha S. The significance of facial patches and type I reaction for the development of facial nerve damage in leprosy. A retrospective study among 1226 paucibacillary leprosy patients. Lepr Rev. 1991;62:143–9.
2. Kiran KU, Hogeweg M, Suneetha S. Treatment of recent facial nerve damage with lagophthalmos, using a semistandard steroid regimen. Lepr Rev. 1991;62:150–4.
3. Courtright P, Hu LF, Li HY, Lewallen S. Multidrug therapy and eye disease in leprosy: a cross-sectional study in the People’s Republic of China. Int J Epidemiol. 1994;23:835–42.
4. Lewallen S, Tungpakorn NC, Kim SH, Courtright P. Progression of eye disease in “cured” leprosy patients: implications for understanding the pathophysiology of ocular disease and for addressing eye care needs. Br J Ophthalmol. 2000;84:817–21.
5. Ffytche TJ. Role of iris changes as a cause of blindness in lepromatous leprosy. Br J Ophthalmol. 1981;65:231–9.